f.duarte
Submits third-party assay reports on material purchased directly. Based in Porto.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
99.28%
n=10
Suppliers covered
9
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042123 | TB-500 | JEEP | JEEP-2602-V8614 | PeptideMeter | 2026-Q3 | 99.93 | 3.80 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042116 | Tirzepatide | JEEP | JEEP-2602-J7978 | Nordanalyt | 2026-Q2 | 99.08 | 5.04 | 105.7 | Buyer-sourced | 0 | PASS |
| AX-2025-019272 | GHRP-6 | AMB | AMB-2506-D5337 | Janoshik | 2025-Q4 | 99.46 | 3.28 | — | Buyer-sourced | 0 | PASS |
| AX-2025-021151 | Semax | SIG | SIG-2504-6873 | Kestrel | 2025-Q3 | 98.37 | 10.29 | — | Buyer-sourced | 1 | FAIL |
| AX-2025-019399 | CJC-1295 (no DAC) | HYB | HYB-2504-N7248 | Janoshik | 2025-Q3 | 99.30 | 4.35 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019224 | Enclomiphene citrate | SinoPep | SNP-2503-J5227 | VendorInvestigate | 2025-Q3 | 98.14 | 4.31 | 94.8 | Buyer-sourced | 0 | FAIL |
| AX-2025-020421 | KPV | MKM | MKM-2504-N4868 | Medutest | 2025-Q2 | 99.93 | 4.41 | 89.0 | Supplier-supplied | 1 | FAIL |
| AX-2025-018469 | Tirzepatide | WWB | WWB-2502-U2990 | Kestrel | 2025-Q1 | 99.25 | 2.49 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019781 | Retatrutide | Homopeptide | HOMO-2409-R4202 | Janoshik | 2025-Q1 | 99.37 | 2.63 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018680 | TB-500 | QSC | QSC-2411-X6249 | Medutest | 2025-Q1 | 99.17 | 5.29 | — | Buyer-sourced | 0 | PASS |